Examples of 'bevacizumab' in a sentence
Meaning of "bevacizumab"
Bevacizumab (adjective) - Bevacizumab is a medication used in the treatment of cancer. In English, it is used as an adjective to describe something related to or associated with this specific medication
Show more definitions
- An anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin.
How to use "bevacizumab" in a sentence
Basic
Advanced
bevacizumab
Bevacizumab may only be available in some situations.
It rarely resulted in discontinuation of bevacizumab treatment or hospitalisation.
One particularly preferred combination includes bevacizumab.
Effect of bevacizumab on the pharmacokinetics of other antineoplastic agents.
Avastin contains the active substance bevacizumab.
Combination of bevacizumab and sunitinib malate.
See also the label for bevacizumab.
Bevacizumab is being studied in this patient population.
Vectibix in combination with bevacizumab and chemotherapy regimens.
Bevacizumab is given as a slow intravenous infusion.
It is not known whether bevacizumab is excreted in human milk.
Bevacizumab previously received an accelerated approval in this setting.
Patients with no prior bevacizumab excluding adjuvant only n.
Bevacizumab and metastatic breast cancer.
It contains the active substance bevacizumab.
See also
Bevacizumab is often given together with other cancer medicines.
Effect of antineoplastic agents on bevacizumab pharmacokinetics.
Assessment of bevacizumab metabolism in rabbits following a single intravenous dose of.
Its effectiveness is similar to that of bevacizumab.
Bevacizumab may adversely affect the wound healing process.
It was proven to be valid in cases of targeted therapy with bevacizumab.
These results were obtained with bevacizumab which is an antibody.
Cancer therapy with a parvovirus combined with bevacizumab.
Bevacizumab has been associated with serious cases of gastrointestinal perforation.
The medicinal ingredient is called bevacizumab.
A maintenance therapy with bevacizumab alone is also a standard practice.
The angiogenesis inhibitor may be bevacizumab.
Bevacizumab should follow chemotherapy.
Safety was consistent with results of prior bevacizumab trials.
The dosage for bevacizumab can be in any amount necessary.
The active substance is bevacizumab.
Bevacizumab in combination with interferon.
Effect of combined trastuzumab and bevacizumab treatment on lung metastasis.
Molecular sequencing in ovarian cancer may predict response to bevacizumab.
The pharmacokinetics of bevacizumab have been studied in a limited number of paediatric patients.
Patients with no prior bevacizumab n.
Bevacizumab has been shown to be embryotoxic and teratogenic when administered to rabbits.
The angiogenesis inhibitor is bevacizumab.
Conclusions on the impact of bevacizumab on gemcitabine pharmacokinetics can not be drawn.
Bevacizumab is a recombinant humanized monoclonal antibody that is used to treat cancer.
Study results demonstrated no significant effect of bevacizumab on the pharmacokinetics of cisplatin.
Bevacizumab combined with interferon slows tumor growth and spread.
Long term effects of the treatment with bevacizumab on fertility are unknown.
Avastin is a cancer medicine that contains the active substance bevacizumab.
The means by which bevacizumab is metabolised has not been directly studied.
There are no clinical trial data on the use of bevacizumab in pregnant women.
Avastin or bevacizumab is one of the most expensive drugs that is currently marketed.
Receiving treatment with chemotherapy together with a medicine containing bevacizumab.
Bevacizumab slows the growth and spread of cancer cells in the body.
Careful patient screening minimizes the risk of bevacizumab adverse events.
